PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC

ABSTRACT Objective: To identify the prevalence of osteoporosis and hypovitaminosis D among patients at the Siriraj Metabolic Bone Disease (MBD) Clinic, and to compare initial vitamin D levels in patients with and without a history of fragility fractures. Methods: Medical records of patients who at...

Full description

Bibliographic Details
Main Authors: AASIS UNNANUNTANA, POJCHONG CHOTIYARNWONG
Format: Article
Language:English
Published: Sociedade Brasileira de Ortopedia e Traumatologia 2017-12-01
Series:Acta Ortopédica Brasileira
Subjects:
Online Access:http://www.scielo.br/pdf/aob/v25n6/1413-7852-aob-25-06-00262.pdf
_version_ 1798016262441271296
author AASIS UNNANUNTANA
POJCHONG CHOTIYARNWONG
author_facet AASIS UNNANUNTANA
POJCHONG CHOTIYARNWONG
author_sort AASIS UNNANUNTANA
collection DOAJ
description ABSTRACT Objective: To identify the prevalence of osteoporosis and hypovitaminosis D among patients at the Siriraj Metabolic Bone Disease (MBD) Clinic, and to compare initial vitamin D levels in patients with and without a history of fragility fractures. Methods: Medical records of patients who attended our MBD clinic between 2012 and 2015 were retrospectively reviewed. Patient baseline demographic, clinical, bone mineral density (BMD), and laboratory data were collected and analyzed. Osteoporosis was diagnosed when patients had a BMD T-score <-2.5 or presented with fragility fractures. Results: There were 761 patients included in this study. Of these, 627 patients (82.4%) were diagnosed with osteoporosis and 508 patients (66.8%) had fragility fractures. Baseline serum 25-hydroxyvitamin D (25(OH)D) levels were available in 685 patients. Of these, 391 patients (57.1%) were diagnosed with hypovitaminosis D. When evaluated only in patients with fragility fractures, the average initial 25(OH)D level was 28.2±11.6 ng/mL, and the prevalence of hypovitaminosis D was 57.6%. Conclusion: A high prevalence of osteoporosis and hypovitaminosis D was found among patients at our clinic; two-thirds of patients had a history of fragility fractures, and no difference in initial 25(OH)D levels was seen between patients with and without fragility fractures. Level of Evidence III, Retrospective Study .
first_indexed 2024-04-11T15:48:01Z
format Article
id doaj.art-5ddbc8ed15c149f89196f22d609c249e
institution Directory Open Access Journal
issn 1413-7852
language English
last_indexed 2024-04-11T15:48:01Z
publishDate 2017-12-01
publisher Sociedade Brasileira de Ortopedia e Traumatologia
record_format Article
series Acta Ortopédica Brasileira
spelling doaj.art-5ddbc8ed15c149f89196f22d609c249e2022-12-22T04:15:28ZengSociedade Brasileira de Ortopedia e TraumatologiaActa Ortopédica Brasileira1413-78522017-12-0125626226510.1590/1413-785220172506174133PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINICAASIS UNNANUNTANAPOJCHONG CHOTIYARNWONGABSTRACT Objective: To identify the prevalence of osteoporosis and hypovitaminosis D among patients at the Siriraj Metabolic Bone Disease (MBD) Clinic, and to compare initial vitamin D levels in patients with and without a history of fragility fractures. Methods: Medical records of patients who attended our MBD clinic between 2012 and 2015 were retrospectively reviewed. Patient baseline demographic, clinical, bone mineral density (BMD), and laboratory data were collected and analyzed. Osteoporosis was diagnosed when patients had a BMD T-score <-2.5 or presented with fragility fractures. Results: There were 761 patients included in this study. Of these, 627 patients (82.4%) were diagnosed with osteoporosis and 508 patients (66.8%) had fragility fractures. Baseline serum 25-hydroxyvitamin D (25(OH)D) levels were available in 685 patients. Of these, 391 patients (57.1%) were diagnosed with hypovitaminosis D. When evaluated only in patients with fragility fractures, the average initial 25(OH)D level was 28.2±11.6 ng/mL, and the prevalence of hypovitaminosis D was 57.6%. Conclusion: A high prevalence of osteoporosis and hypovitaminosis D was found among patients at our clinic; two-thirds of patients had a history of fragility fractures, and no difference in initial 25(OH)D levels was seen between patients with and without fragility fractures. Level of Evidence III, Retrospective Study .http://www.scielo.br/pdf/aob/v25n6/1413-7852-aob-25-06-00262.pdfOsteoporotic fractureBone diseases, metabolicBone densityVitamin DOsteoporosis.
spellingShingle AASIS UNNANUNTANA
POJCHONG CHOTIYARNWONG
PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
Acta Ortopédica Brasileira
Osteoporotic fracture
Bone diseases, metabolic
Bone density
Vitamin D
Osteoporosis.
title PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_full PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_fullStr PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_full_unstemmed PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_short PREVALENCE OF OSTEOPOROSIS AND HYPOVITAMINOSIS D AT SIRIRAJ METABOLIC BONE DISEASE CLINIC
title_sort prevalence of osteoporosis and hypovitaminosis d at siriraj metabolic bone disease clinic
topic Osteoporotic fracture
Bone diseases, metabolic
Bone density
Vitamin D
Osteoporosis.
url http://www.scielo.br/pdf/aob/v25n6/1413-7852-aob-25-06-00262.pdf
work_keys_str_mv AT aasisunnanuntana prevalenceofosteoporosisandhypovitaminosisdatsirirajmetabolicbonediseaseclinic
AT pojchongchotiyarnwong prevalenceofosteoporosisandhypovitaminosisdatsirirajmetabolicbonediseaseclinic